13F Holdings
中文EN

TNON Tenon Medical, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1560293 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY72.3%
TTM net income YoY-32.7%
TTM EPS YoY162.1%
Revenue 3-yr CAGR32.5%
Net income 3-yr CAGR—

Margins

Gross margin66.9%
Operating margin-225.9%
Net margin-305.1%
FCF margin-193.1%
EBITDA margin-220.7%

Returns

ROE-242.5%
ROA-128.0%
ROIC (approx.)-863.4%
Asset turnover0.42x

Leverage & solvency

Liabilities / assets43.1%
Debt / equity0.00x
Current ratio2.93x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.61x
Accruals ratio-50.2%
Payout ratio—
Capex / revenue7.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$3.94M$3.28M$2.93M$691,000$160,000
Cost of revenue$1.59M$1.57M$1.69M$1.33M$55,000
Gross profit$2.36M$1.71M$1.24M-$641,000$105,000
R&D expense$2.15M$2.60M$3.16M$2.83M$1.72M
SG&A expense$6.97M$7.76M$7.03M$7.42M$2.71M
Operating income-$12.79M-$13.77M-$15.73M-$18.73M-$6.46M
Interest expense—$34,000$21,000$354,000$621,000
Pretax income-$12.56M-$13.67M-$15.57M-$18.89M-$7.08M
Net income-$12.56M-$13.67M-$15.58M-$18.92M-$7.05M
EBITDA-$12.53M-$13.36M-$15.53M-$18.65M-$6.46M
EPS (basic)-1.70-11.26-68.64-23.62-7.81
EPS (diluted)-1.70-11.26-68.64-23.62-7.81
Weighted avg. shares (diluted)7,3841,214227801903
Balance sheet
Cash & equivalents$3.76M$6.54M$2.43M$2.13M$2.92M
Short-term investments———$6.44M$4.40M
Receivables$1.70M$863,000$518,000$228,000$76,000
Inventory$1.05M$606,000$554,000$415,000$188,000
Current assets$6.77M$8.21M$3.89M$9.35M$7.67M
PP&E, net$918,000$752,000$961,000$793,000$101,000
Goodwill$2.41M————
Intangibles$485,000————
Total assets$10.76M$9.84M$6.34M$11.09M$9.27M
Current liabilities$3.21M$1.87M$3.14M$2.53M$15.27M
Total liabilities$5.72M$3.87M$5.57M$4.84M$16.18M
Shareholders' equity$5.04M$5.97M$778,000$6.25M-$20.55M
Shares outstanding310,0363.14M325,0391.12M989,954
Cash flow statement
Operating cash flow-$10.74M-$9.88M-$12.18M-$12.03M-$4.29M
Capital expenditure$273,000$186,000$361,000$847,000$102,000
Free cash flow-$11.02M-$10.06M-$12.54M-$12.87M-$4.39M
Investing cash flow-$1.02M-$186,000$6.14M-$2.88M-$4.50M
Financing cash flow$8.99M$14.12M$6.30M$14.11M$11.47M
Depreciation & amortization$262,000$408,000$199,000$78,000$2,000
Stock-based compensation$1.69M$3.85M$4.14M$2.90M$377,000

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.